The 2023-2028 Outlook for Antidepressant Pharmaceuticals in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for antidepressant pharmaceuticals in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. grows over time. I...
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Antidepressant Drugs in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for antidepressant drugs in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. grows over time. In order to...
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Antidepressant and Anti-Anxiety Drugs in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for antidepressant and anti-anxiety drugs in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. grows over ...
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Anticoagulation Therapies in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for anticoagulation therapies in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. grows over time. In ord...
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Anticonvulsants for Krabbe Disease Treatments in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for anticonvulsants for Krabbe disease treatments in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. gro...
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Anticoagulants in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for anticoagulants in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. grows over time. In order to make ...
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Anticoagulant Reversal Drugs in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for anticoagulant reversal drugs in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. grows over time. In ...
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Anticoagulant Drugs in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for anticoagulant drugs in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. grows over time. In order to ...
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Anticholinergic Motion Sickness Treatments in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for anticholinergic motion sickness treatments in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. grows ...
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Antibody Drugs in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for antibody drugs in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. grows over time. In order to make ...
11/28/2022 | Japan Outlook 2023
